Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Vaccine-Induced Thrombocytopenia with Severe Headache
NEJM 385:doi:101056/NE0a2114255, Schonborn, L., et al, 2021
Vaccine-Induced Thrombocytopenia with Severe Headache
NEJM 385:doi:10.1056/NEJMc2112974, Salih, F.,et al, 2021
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
BMJ 359:J5058, Lopez-Lopez, J.A.,et al, 2017
Triptans for Symptomatic Treatment of Migraine Headache
BMJ 348:g2285, Pringsheim, T. & Becker, W.J., 2014
Lamotrigine and Aseptic Meningitis
Neurol 78:921-927, Simms,K.M.,et al, 2012
Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012
Neuro-Sweets Disease
Pract Neurol 12:126-130, Maxwel,G.,et al, 2012
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
Tricyclic Antidepressants and Headaches: Systematic Review and Meta-Analysis
BMJ 341:c5222, Jackson,J.L.,et al, 2010
Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008
Serotonin Syndrome Associated With Triptan Monotherapy
NEJM 358:2185-2186, Soldin,O.P. &Tonning,J.M., 2008
Give Dipyridamole with Aspirin Instead of Aspirin Alone to Prevent Vascular Events After Ischaemic Stroke or TIA
BMJ 334:901, Sudlow,C., 2007
Chronic Daily Headache in Adolescents
Neurol 66:193-197, Wang,S.-J.,et al, 2006
Analgesic Overuse Among Adolescents With Headache, The Head-HUNT-Youth Study
Neurol 66:198-201,160, Dyb,G.,et al, 2006
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Reversible Anorgasmia With Topiramate Therapy for Migraine
Neurol 65:1333-1334, Newman,L.C.,et al, 2005
Acute Disseminated Encephalomyelitis
Arch Neurol 62:1673-1680, Menge,T.,et al, 2005
Neurologic Adverse Events Associated With Smallpox Vaccination in the United States, 2002-2004
JAMA 294:2744-2750, Sejvar,J.J.,et al, 2005
Trpitans in Migraine
Neurol 62:563-568, Hall,G.C.,et al, 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Almotriptan (AXERT) and Frovatriptan (FROVA) for Migraine
The Medical Letter 44:19-20, , 2002
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
What Matters is Not the Differences Between Triptans, but the Differences Between Patients
Arch Neurol 58:1481-1482, Saper,J.R., 2001
Triptans Are All Different
Arch Neurol 58:1479-1480,1482, Rapoport,A.M.&Tepper,S.J., 2001
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Practice Parameter: Evidence-Based Guidelines for Migraine Headache (an Evidence-Based Review)
Neurol 55:754-763, Silberstein,S.D. et al, 2000
Central Anticholinergic Syndrome on Therapeutic Doses of Cyproheptadine
Pediatrics 103:158-160, Watemberg,N.M.,et al, 1999
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999
Tiagabine
Lancet 351:203-207, Leach,J.P.&Brodie,M.J., 1998
Rizatriptan (MAXALT) for the Acute Treatment of Migraine & Migraine Recurrence, Rizatriptan 022 Study Grp
Headache 38:281-287, Tuchman,T.J.,et al, 1998
A Placebo-ControlledCrossover Study of Rizatriptan in the Treatment of Multiple Migraine Attacks
Neurol 52:773-781, Kramer,M.S.,et al, 1998
Acute Therapy for Cluster Headache with Sumatriptan:Findings of a One-Year Long-Term Study
Neurol 51:980-911, Gobel,H.,et al, 1998
Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse
Headache 38:478-480, Nighoghossian,N.,et al, 1998
Butorphanol (Stadol) :A Study in Problems of Current Drug Information and Control
Neurol 48:1156-1160, Fisher,M.A.&Glass,S., 1997
Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997